Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: Experience after 2 years in France

Journal of Infectious Diseases

Volumn 196, Issue 3, 2007, Pages 377-383

  Semaille, Caroline ^a   Barin, Francis ^b   Cazein, Françoise ^a   Pillonel, Josiane ^a   Lot, Florence ^a   Brand, Denys ^b   Plantier, Jean Christophe ^c   Bernillon, Pascale ^a   Le Vu, Stéphane ^a   Pinget, Roselyne ^a   Desenclos, Jean Claude ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; EPIDEMIC; FEMALE; FRANCE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; DISEASE OUTBREAKS; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHYLOGENY; RISK FACTORS; TIME FACTORS;

EID: 34447619698     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519387     Document Type: Article

References (30)

1. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-8.
2. Barin F, Meyer L, Lancar R, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005; 43:4441-7.
3. Couturier E, Damond F, Roques P, et al. HIV-1 diversity in France, 1996-1998. The AC 11 Laboratory Network. AIDS 2000; 14:289-96.
4. Barin F, Courouce AM, Pillonel J, Buzelay L. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 1997; 11:1503-8.
5. Descamps D, Chaix ML, Andre P, et al. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr 2005; 38:545-52.
6. Aggarwal I, Smith M, Tatt ID, et al. Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom. J Acquir Immune Defic Syndr 2006; 41:201-9.
7. Lospitao E, Alvarez A, Soriano V, Holguin A. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med 2005; 6:313-20.
8. Esteves A, Parreira R, Venenno T, et al. Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002; 18:313-25.
9. Lot F, Semaille C, Cazein F, et al. Preliminary results from the new HIV surveillance system in France. Euro Surveill 2004; 9:34-7.
10. Barin F, Plantier JC, Brand D, et al. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 2006; 78(Suppl 1):S13-8.
11. Plantier JC, Damond F, Lasky M, et al. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:432-41.
12. Brand D, Beby-Defaux A, Mace M, et al. First identification of HIV-1 groups M and O dual infections in Europe. AIDS 2004; 18:2425-8.
13. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41:95-8.
14. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5:150-63.
15. Kimura MA. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16:111-20.
16. Puchhammer-Stockl E, Schmied B, Rieger A, et al. Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity. J Clin Microbiol 2005; 43:497-8.
17. Guy RJ, Breschkin AM, Keenan CM, Catton MG, Enriquez AM, Hellard ME. Improving HIV surveillance in Victoria: the role of the "detuned" enzyme immunoassay. J Acquir Immune Defic Syndr 2005; 38:495-9.
18. Velter A, ed. Rapport enquête PresseGay 2006. Saint Maurice: Institut de Veille Sanitaire, 2007.
19. Beltzer N, Lagarde M, Wu-Zhou X, Vongmany N, Grémy I. Les connaissances, attitudes, croyances et comportements face au VIH/sida en France en 2004: evolutions 1992-1994-1998-2001-2004. Paris: Observatoire Régional de la Santé d'Ile-de-France, 2005.
20. Couturier E, Michel A, Janier M, Dupin N, Semaille C. Syphilis surveillance in France, 2000-2003. Euro Surveill 2004; 9(12):8-10.
21. Herida M, Sednaoui P, Couturier E, et al. Rectal lymphogranuloma venereum, France. Emerg Infect Dis 2005; 11:505-6.
22. Institut de veille sanitaire. Dépistage et diagnostic du VIH dans les laboratoires: LaboVIH 2004. Surveillance du VIH/sida en France. Rapport no. 3. Données au 30 juin 2005. Saint-Maurice: Institut de Veille Sanitaire, 2006:16-9.
23. Borrel C. Enquêtes annuelles de recensements 2004 et 2005. Près de 5 millions d'immigrés à la mi-2004. Insee Première 2006; 1098:1-4.
24. Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS 2003; 17:2547-60.
25. McCutchan FE. Global epidemiology of HIV. J Med Virol 2006; 78(Suppl 1):S7-12.
26. Niama FR, Toure-Kane C, Vidal N, et al. HIV-1 subtypes and recombinants in the Republic of Congo. Infect Genet Evol 2006; 6:337-43.
27. Turbica I, Simon F, Besnier JM, et al. Temporal development and prognostic value of the antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection. J Med Virol 1997; 52:309-15.
28. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001; 17:137-46.
29. Plantier JC, Dachraoui R, Lemée V, et al. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19:391-7.
30. Chaix ML, Descamps D, Harzic M, et al. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 2003; 17:2635-43.